Alogliptin, a dipeptidylpeptidase-4 inhibitor, for patients with diabetes mellitus type 2, induces tolerance to focal cerebral ischemia in non-diabetic, normal mice.
published in: Brain Research
date of publication: 2013-04-17
language: English
main subject: type 2 diabetes, cerebral infarction
Cites articles
There is nothing here
Article - wd:Q34679065